Conceptio › Archive › Arpha Oai Pmh Endpoint
Arpha Oai Pmh Endpointmetadata only

Icotrokinra as a selective IL-23 receptor inhibitor: a new oral therapeutic strategy in psoriasis

Bresa,Adhurim et al.
Arpha Oai Pmh Endpoint · Other
Open Source ↗
biologic therapy, guselkumab, icotrokinra, il-23, il-23 receptor, pasi response, psoriasis, risankizumab
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 310604
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.